•  
  •  
 

Abstract

The increasing use of antibiotics over recent decades has significantly affected global public health, primarily through the emergence of antimicrobial resistance (AMR), which contributes to higher morbidity, mortality, and economic burden. As a regional referral hospital, Bekasi Regency General Hospital faces substantial challenges related to high resistance rates, with multidrug-resistant organisms (MDROs) showing MRSA at 22.22% and ESBL at 40% in 2024. This study evaluated the implementation of the Prospective System Antimicrobial Regulation Program (RASPRO) in relation to resistance patterns, antibiotic cost efficiency, and supporting roles of governance, human resources, and monitoring systems. A quantitative prospective cohort design was applied, analyzing inpatient data before and after RASPRO implementation. Antibiotic utilization was assessed using Defined Daily Dose (DDD), therapeutic rationality was evaluated using the Gyssens method, and procurement cost efficiency was examined. The results showed improved rational antibiotic use and reduced consumption of broad-spectrum antibiotics (third/fourth-generation cephalosporins, meropenem, levofloxacin, ciprofloxacin, vancomycin), while narrow-spectrum antibiotics (cefazolin, cefotaxime, gentamicin, metronidazole) increased as definitive therapy. However, procurement costs for certain antibiotics increased. The effectiveness of RASPRO relies heavily on management commitment and collaboration within the Antimicrobial Stewardship Team (PPRA), supported by consistent prospective audits. While RASPRO improves rational antibiotic use, further evaluation of procurement cost efficiency is needed for program sustainability.

References

Aiesh, B.M. et al. (2023) ‘Impact of an antibiotic stewardship program on antibiotic utilization, bacterial susceptibilities, and cost of antibiotics’, Scientific Reports, 13(1), p. 5040. Available at: https://doi.org/10.1038/s41598-023-32329-6.

Barlam, T.F. et al. (2016) ‘Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America’, Clinical Infectious Diseases, 62(10), pp. e51–e77. Available at: https://doi.org/10.1093/cid/ciw118.

Baur, D. et al. (2017) ‘Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis’, The Lancet Infectious Diseases, 17(9), pp. 990–1001. Available at: https://doi.org/10.1016/S1473-3099(17)30325-0.

Davey, P. et al. (2017) ‘Interventions to improve antibiotic prescribing practices for hospital inpatients’, Cochrane Database of Systematic Reviews, 2017(2). Available at: https://doi.org/10.1002/14651858.CD003543.pub4.

Funiciello, E. et al. (2024) ‘Identifying AWaRe indicators for appropriate antibiotic use: a narrative review’, Journal of Antimicrobial Chemotherapy, 79(12), pp. 3063–3077. Available at: https://doi.org/10.1093/jac/dkae370.

Gulam, S.M. et al. (2025) ‘Prospective Audit and Feedback of Targeted Antimicrobials Use at a Tertiary Care Hospital in the United Arab Emirates’, Antibiotics, 14(3), p. 237. Available at: https://doi.org/10.3390/antibiotics14030237.

Herawati, F. et al. (2020) ‘Interview-based cross-sectional needs assessment to advance the implementation of an effective antibiotic stewardship program in Indonesian hospitals’, Health Policy OPEN, 1, p. 100002. Available at: https://doi.org/10.1016/j.hpopen.2019.100002.

Kadariswantiningsih, I.N. et al. (2025) ‘Antibiotic resistance in Indonesia: A systematic review and meta‐analysis of extended‐spectrum beta‐lactamase‐producing bacteria (2008–2024)’, Tropical Medicine & International Health, 30(4), pp. 246–259. Available at: https://doi.org/10.1111/tmi.14090.

Kementerian Kesehatan RI (2021) Panduan Penatagunaan Antimikroba di Rumah Sakit. Jakarta. Available at: https://pulmo-ua.com/wp-content/uploads/2021/11/BUKU-Panduan-PGA-2021-FINAL.pdf.

Krishnamoorthy, Y. et al. (2025) ‘Global impact of antimicrobial stewardship programs in Healthcare: An umbrella review of effectiveness, cost-efficiency, and implementation strategies’, Journal of Infection and Chemotherapy, 31(8), p. 102753. Available at: https://doi.org/10.1016/j.jiac.2025.102753.

Limato, R. et al. (2022) ‘A qualitative study of barriers to antimicrobial stewardship in Indonesian hospitals: governance, competing interests, cost, and structural vulnerability’, Antimicrobial Resistance & Infection Control, 11(1), p. 85. Available at: https://doi.org/10.1186/s13756-022-01126-7.

Mazzitelli, M. et al. (2025) ‘Outcomes of Implementing a Multidimensional Antimicrobial Stewardship Program in a Medical Ward in a Third-Level University Hospital in Northern Italy’, Antibiotics, 14(7), p. 683. Available at: https://doi.org/10.3390/antibiotics14070683.

Qibtiyah, M., Wahyuhadi, J. and Khotib, J. (2023) ‘The impact of antimicrobial stewardship on reserve antibiotic use and procuring cost’, Pharmacy Education, 23(4), pp. 149–153. Available at: https://doi.org/10.46542/pe.2023.234.149153.

Schuts, E.C. et al. (2016) ‘Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis’, The Lancet Infectious Diseases, 16(7), pp. 847–856. Available at: https://doi.org/10.1016/S1473-3099(16)00065-7.

Septimus, E. (2014) ‘Antimicrobial Stewardship—Qualitative and Quantitative Outcomes: The Role of Measurement’, Current Infectious Disease Reports, 16(11), p. 433. Available at: https://doi.org/10.1007/s11908-014-0433-x.

Setiawan, E. et al. (2022) ‘Hospital-Based Antimicrobial Stewardship Programs Used in Low- and Middle-Income Countries: A Scoping Review’, Microbial Drug Resistance, 28(5), pp. 566–584. Available at: https://doi.org/10.1089/mdr.2021.0363.

Sinto, R. et al. (2024) ‘A nationwide mixed-methods study of gaps and barriers to implementation of antimicrobial stewardship programmes in hospitals in Indonesia’, Journal of Hospital Infection, 154, pp. 77–87. Available at: https://doi.org/10.1016/j.jhin.2024.10.001.

Smith, D.R., Temime, L. and Opatowski, L. (2021) ‘Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control’, eLife, 10. Available at: https://doi.org/10.7554/eLife.68764.

Walsh, T.R. et al. (2023) ‘Antimicrobial Resistance: Addressing a Global Threat to Humanity’, PLOS Medicine, 20(7), p. e1004264. Available at: https://doi.org/10.1371/journal.pmed.1004264.

World Health Organization (2022) Global antimicrobial resistance and use surveillance system (‎GLASS)‎ report: 2022. Geneva. Available at: https://www.who.int/publications/i/item/9789240062702.

Zay Ya, K. et al. (2023) ‘Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally’, JAMA Network Open, 6(2), p. e2253806. Available at: https://doi.org/10.1001/jamanetworkopen.2022.53806.

Bahasa Abstract

Peningkatan penggunaan antibiotik dalam beberapa dekade terakhir telah memberikan dampak yang signifikan terhadap kesehatan masyarakat global, terutama melalui munculnya resistensi antimikroba (AMR) yang berkontribusi pada peningkatan angka kesakitan, kematian, dan beban ekonomi. Sebagai rumah sakit rujukan daerah, RSUD Kabupaten Bekasi menghadapi tantangan serius terkait tingginya tingkat resistensi, dengan angka MDRO MRSA mencapai 22,22% dan ESBL sebesar 40% pada tahun 2024. Penelitian ini bertujuan mengevaluasi pelaksanaan Program Regulasi Antimikroba Sistem Prospektif (RASPRO) terhadap pola resistensi, efisiensi biaya antibiotik, serta peran tata kelola, sumber daya manusia, dan sistem pemantauan yang mendukung. Dengan desain kohort prospektif kuantitatif, data pasien rawat inap sebelum dan sesudah penerapan RASPRO dianalisis berdasarkan pola penggunaan antibiotik (Defined Daily Dose/DDD), rasionalitas terapi menurut metode Gyssens, serta efisiensi biaya pembelian. Hasil penelitian menunjukkan adanya perbaikan rasionalitas penggunaan antibiotik dan penurunan konsumsi antibiotik spektrum luas (cephalosporin generasi ke-3 dan ke-4, meropenem, levofloxacin, ciprofloxacin, vancomycin), diiringi peningkatan penggunaan antibiotik spektrum sempit (cefazoline, cefotaxime, gentamisin, metronidazole) sebagai terapi definitif. Namun, terjadi peningkatan biaya pengadaan untuk beberapa jenis antibiotik tertentu. Keberhasilan RASPRO dipengaruhi oleh komitmen manajemen serta kolaborasi Tim Pengendalian Resistensi Antimikroba (PPRA), ditunjang audit prospektif yang konsisten. RASPRO terbukti efektif meningkatkan rasionalitas penggunaan antibiotik, tetapi perlu evaluasi lebih lanjut terkait efisiensi biaya pengadaan demi keberlanjutan program.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.